Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

POC Diagnostic Grand Challenge Contracting Update

by Global Biodefense Staff
March 26, 2013

The Defense Threat Reduction Agency (DTRA) has further detailed contractor requirements for the “Open Innovation Services for Prizes and Challenges” effort to assist DTRA staff in defining, developing, advertising, and administering a large market stimulatory grand challenge aimed at solving problems related to point-of-care or point-of-need diagnostics for known, emerging, or engineered pathogens.   

The agency last month announced an intention to enter into limited competition between responding sources “X Prize Foundation” and the team of “Booz-Allen-Hamilton/Innocentive, Inc.” for the effort. 

The selected contractor will be responsible for the conduct of all activities to assist in administering the grand challenge to develop and acquire advanced point-of-need or point-of-care diagnostics. 

The Base Period requires the contractor to work with DTRA and DoD representatives to clearly define the problem to be solved; identify technological, commercial, market and any engineering barriers to solving the problem. The contractor will then be charged with identifying potential “solver communities” and generating a challenge prize competition concept and prize structure designed to stimulate the market and overcome the barriers previously identified. 

Option Period 1 calls for further development of competition rules including those which stimulate the market to overcome specific challenges in the Point-of-Need or Point-of-Care diagnostics fields including Clinical Laboratory Improvement Amendments (CLIA) waiver and Current Procedural Terminology (CPT) code award. 

This phase also establishes testing and evaluation protocols and address how the offeror will determine an appropriate intellectual property strategy, salient to the scope, technical, and market requirements of the prize competition and which also accomplishes the government’s goals of stimulation of the market and long-term commercial viability and availability of the solution.

The contractor will then develop a public awareness and education campaign and a framework to facilitate collaboration or teaming among potential solvers.

Option Period 2 is the execution of the Grand Challenge competition, testing and evaluation of all solutions submitted, and making reports and recommendations to the Government which solution should be awarded the prize. If the contract period of performance ends before a single solution meets all metrics, the contractor is asked to rank all solutions and recommend to the Government top solutions.

Further details are available under Solicitation Number: HDTRA1-13-R-0012. The proposal deadline for the limited competition candidates is April 8, 2013.

Tags: AwardsDefense Threat Reduction AgencyPOC Diagnostics

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC